Preclinical Product
Development

We transform validated discoveries into development-ready therapeutic and diagnostic candidates. By integrating experimental rigor, computational insight, and scalable design, we advance programs toward clinical and regulatory readiness.

Translating discovery insights into development-ready candidates.

We bridge laboratory science and human application through rigorous preclinical validation, scalable manufacturing, and regulatory strategy.

  • We design and validate robust biochemical and cell-based assays to measure biological activity, potency, and mechanism of action. Assay platforms are optimized for reproducibility, scalability, and regulatory alignment. 

  • Our high-throughput screening infrastructure enables rapid evaluation of compound libraries and biologic candidates. Automated screening systems support hit identification, lead optimization, and structure–activity relationship analysis. 

  • Data science underpins candidate optimization and decision-making. We integrate experimental data, preclinical modeling, and statistical analysis to identify trends, reduce risk, and guide portfolio prioritization. 

  • Machine learning models support predictive target validation, compound design, biomarker discovery, and safety signal identification. AI-driven analytics accelerate candidate refinement and enhance probability of clinical success. 

  • Pharmacokinetic/pharmacodynamic (PK/PD) modeling and in silico simulations inform dose selection, safety margins, and trial design. Mechanistic and systems-level models reduce uncertainty prior to first-in-human studies. 

  • Our regulatory team develops integrated strategies for IND submission and global regulatory engagement. We ensure compliance with GLP, GMP, and ICH standards while maintaining proactive dialogue with regulatory authorities. 

  • We develop scalable, GMP-compliant manufacturing processes with validated analytical methods and stability programs. CMC strategy ensures product consistency, quality assurance, and readiness for clinical development.